{"product_id":"combo-noopept-fasoracetam-prl-8-53-teacrina","title":"Combo Noopept + Fasoracetam + PRL-8-53 + Teacrina","description":"\u003cstyle\u003e\n.fnx-self{--b:#1264ff;--b2:#2d7cff;--c:#2be1ff;--bg:#020a1b;--bg2:#041936;--txt:#f7fbff;--cp:#b5cae3;--ln:rgba(125,190,255,.17);width:min(1180px,100%);margin:36px auto;color:var(--txt);font-family:Inter,-apple-system,BlinkMacSystemFont,\"Segoe UI\",sans-serif;position:relative}.fnx-self*,.fnx-self*::before,.fnx-self*::after{box-sizing:border-box}.fnx-self h2,.fnx-self h3,.fnx-self p{margin-top:0}.fnx-self p{color:var(--cp);line-height:1.65}.fnx-self .kicker{margin:0 0 12px;color:var(--c);font-size:10px;font-weight:800;letter-spacing:.19em;text-transform:uppercase}.fnx-presentation{position:relative;overflow:hidden;display:grid;grid-template-columns:.86fr 1.14fr;gap:clamp(30px,5vw,68px);align-items:end;padding:clamp(34px,5vw,60px);margin-bottom:24px;border:1px solid rgba(161,210,255,.18);border-radius:26px;background:radial-gradient(42rem 27rem at 15% 20%,rgba(43,225,255,.11),transparent 66%),radial-gradient(35rem 25rem at 100% 90%,rgba(45,115,255,.22),transparent 68%),linear-gradient(135deg,rgba(7,58,135,.92),rgba(2,18,49,.97));box-shadow:0 28px 80px rgba(0,8,38,.3),inset 0 1px rgba(255,255,255,.08)}.fnx-presentation::before{content:\"\";position:absolute;width:55%;height:220%;left:-45%;top:-70%;transform:rotate(17deg);background:linear-gradient(90deg,transparent,rgba(255,255,255,.055),transparent);animation:fnxGlass 9s ease-in-out infinite;pointer-events:none}@keyframes fnxGlass{0%,60%{left:-45%;opacity:0}70%{opacity:.7}100%{left:120%;opacity:0}}.fnx-presentation-copy{position:relative;z-index:2}.fnx-presentation h2{max-width:11ch;margin:0 0 18px;color:#fff;font-size:clamp(36px,4.5vw,61px);line-height:.98;letter-spacing:-.055em;font-weight:780}.fnx-presentation-copy\u003ep:last-child{max-width:42ch;margin-bottom:0;font-size:15px}.fnx-facts{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));margin:0}.fnx-fact{min-height:106px;padding:20px 22px 20px 0;border-top:1px solid var(--ln)}.fnx-fact:nth-child(even){padding-left:28px;border-left:1px solid rgba(125,190,255,.1)}.fnx-fact dt{margin:0 0 9px;color:#79b9ff;font-size:9px;font-weight:800;letter-spacing:.16em;text-transform:uppercase}.fnx-fact dd{margin:0;color:#fff;font-size:15px;font-weight:720}.fnx-stock{display:flex;align-items:center;gap:9px}.fnx-stock::before{content:\"\";width:7px;height:7px;flex:0 0 auto;border-radius:50%;background:#63ff93;box-shadow:0 0 8px #63ff93,0 0 20px rgba(99,255,147,.55)}.fnx-quick{position:relative;overflow:hidden;margin:0 0 24px;padding:clamp(36px,5vw,56px);border-top:1px solid rgba(137,196,255,.18);border-bottom:1px solid rgba(137,196,255,.12);background:radial-gradient(38rem 22rem at 85% 20%,rgba(45,115,255,.16),transparent 66%),linear-gradient(120deg,rgba(8,64,146,.45),rgba(3,19,53,.72))}.fnx-quick-head{position:relative;z-index:2;display:grid;grid-template-columns:1fr .62fr;gap:35px;align-items:end;margin-bottom:28px}.fnx-quick h2{max-width:12ch;margin:0;color:#fff;font-size:clamp(34px,4vw,52px);line-height:.98;letter-spacing:-.05em}.fnx-quick-head\u003ep{margin-bottom:0;max-width:46ch;font-size:14px}.fnx-quick-grid{position:relative;z-index:2;display:grid;grid-template-columns:repeat(3,minmax(0,1fr));border-top:1px solid var(--ln)}.fnx-key{position:relative;min-height:190px;padding:25px 26px 22px 0;transition:transform .35s cubic-bezier(.16,1,.3,1),background .35s ease}.fnx-key+.fnx-key{padding-left:26px;border-left:1px solid rgba(125,190,255,.1)}.fnx-number{display:inline-grid;place-items:center;width:32px;height:32px;margin-bottom:23px;border:1px solid rgba(43,225,255,.24);border-radius:50%;color:#8adfff;font-size:9px;font-weight:800;box-shadow:0 0 22px rgba(43,225,255,.08)}.fnx-key h3{margin:0 0 9px;color:#fff;font-size:17px}.fnx-key p{margin:0;font-size:13px}.fnx-deep{position:relative;overflow:hidden;margin:0;border:1px solid rgba(137,196,255,.18);border-radius:26px;background:linear-gradient(145deg,rgba(5,46,112,.93),rgba(2,15,40,.98));box-shadow:0 32px 85px rgba(0,5,30,.3),inset 0 1px rgba(255,255,255,.06)}.fnx-deep\u003esummary{position:relative;display:grid;grid-template-columns:42px 1fr auto;gap:16px;align-items:center;min-height:92px;padding:19px 28px;color:#fff;cursor:pointer;list-style:none;background:radial-gradient(34rem 15rem at 10% 0,rgba(43,225,255,.09),transparent 65%)}.fnx-deep\u003esummary::-webkit-details-marker{display:none}.fnx-signal{position:relative;width:38px;height:38px;border:1px solid rgba(43,225,255,.34);border-radius:50%;background:radial-gradient(circle,#b4f9ff 0 2px,transparent 3px);box-shadow:0 0 18px rgba(43,225,255,.12),inset 0 0 18px rgba(45,115,255,.12)}.fnx-deep-label{display:grid;gap:3px}.fnx-deep-label strong{font-size:18px}.fnx-deep-label small{color:#a9c3df;font-size:12px}.fnx-arrow{display:grid;place-items:center;width:37px;height:37px;border:1px solid rgba(43,225,255,.25);border-radius:50%;color:#71dcff;transition:transform .4s cubic-bezier(.16,1,.3,1)}.fnx-deep[open] .fnx-arrow{transform:rotate(180deg)}.fnx-history,.fnx-science,.fnx-identity,.fnx-questions,.fnx-sources{padding:clamp(54px,7vw,88px);border-top:1px solid rgba(125,190,255,.1)}.fnx-history{display:grid;grid-template-columns:.72fr 1.28fr;gap:clamp(38px,6vw,84px);background:radial-gradient(40rem 24rem at 15% 25%,rgba(45,115,255,.13),transparent 70%),linear-gradient(145deg,rgba(3,28,75,.98),rgba(3,38,96,.82))}.fnx-history h2,.fnx-science-copy h2,.fnx-questions h2{margin:0 0 20px;color:#fff;font-size:clamp(42px,5vw,67px);line-height:.96;letter-spacing:-.055em}.fnx-history h2{max-width:8ch}.fnx-tl{position:relative;margin:0;padding:0 0 0 43px;list-style:none}.fnx-tl::before{content:\"\";position:absolute;left:8px;top:7px;bottom:8px;width:1px;background:linear-gradient(180deg,#a5f7ff,#2bdfff 30%,#2d73ff 72%,transparent);box-shadow:0 0 12px rgba(43,225,255,.7),0 0 28px rgba(45,115,255,.32)}.fnx-tl li{position:relative;padding:0 0 38px;opacity:.76}.fnx-tl li:last-child{padding-bottom:0}.fnx-node{position:absolute;left:-42px;top:4px;width:17px;height:17px;border:1px solid #76e8ff;border-radius:50%;background:#073270;box-shadow:0 0 0 5px rgba(43,225,255,.04),0 0 18px rgba(43,225,255,.22)}.fnx-date{margin:0 0 7px!important;color:#63d9ff!important;font-size:9px;font-weight:800;letter-spacing:.18em}.fnx-tl h3{margin:0 0 8px;color:#fff;font-size:20px}.fnx-tl p:last-child{margin-bottom:0;font-size:14px}.fnx-science{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(40px,6vw,84px);align-items:center;background:radial-gradient(48rem 32rem at 22% 50%,rgba(43,225,255,.07),transparent 67%),radial-gradient(48rem 32rem at 90% 15%,rgba(45,115,255,.18),transparent 67%),linear-gradient(130deg,#042b76,#031532 72%)}.fnx-molecule{position:relative;min-height:530px;display:grid;place-items:center;isolation:isolate;perspective:1000px}.fnx-molecule-stage{position:relative;width:100%;max-width:640px;min-height:430px;display:grid;place-items:center;transform-style:preserve-3d}.fnx-molecule-svg{position:relative;z-index:3;width:108%;max-width:670px;height:auto;filter:drop-shadow(0 0 9px rgba(43,225,255,.46)) drop-shadow(0 0 26px rgba(45,115,255,.22))}.fnx-platform{position:absolute;left:15%;right:15%;bottom:7%;height:16%;z-index:-1;border-radius:50%;background:radial-gradient(ellipse,rgba(210,252,255,.27),rgba(43,225,255,.18) 12%,rgba(45,115,255,.08) 36%,transparent 68%)}.fnx-molecule-meta{position:absolute;left:1%;bottom:1%;z-index:6;padding:12px 15px;border-left:1px solid rgba(43,225,255,.36);background:linear-gradient(90deg,rgba(2,18,44,.74),transparent)}.fnx-molecule-meta strong{display:block;color:#e4fcff;font-size:11px;letter-spacing:.1em}.fnx-molecule-meta span{display:block;margin-top:5px;color:#8db9da;font-size:9px;line-height:1.5}.fnx-science-copy h2{max-width:11ch}.fnx-science-lead{margin-bottom:28px!important;font-size:15px}.fnx-topic{display:grid;grid-template-columns:38px 1fr;gap:14px;padding:17px 0;border-top:1px solid var(--ln)}.fnx-topic\u003espan{color:#49d9ff;font-size:10px;font-weight:800}.fnx-topic h3{margin:0 0 5px;color:#fff;font-size:16px}.fnx-topic p{margin:0;font-size:13px}.fnx-identity{display:grid;grid-template-columns:.72fr .52fr 1.18fr;gap:clamp(30px,5vw,62px);align-items:center;background:linear-gradient(145deg,rgba(3,24,65,.98),rgba(5,52,126,.82))}.fnx-identity h2{max-width:10ch;margin:0 0 18px;color:#fff;font-size:clamp(36px,4.2vw,56px);line-height:.98;letter-spacing:-.05em}.fnx-formula{text-align:center;color:#fff;font-size:clamp(42px,5vw,68px);font-weight:300;letter-spacing:-.04em;text-shadow:1px 1px 0 #0a2e74,2px 2px 0 rgba(43,225,255,.22),0 0 28px rgba(43,225,255,.18)}.fnx-formula sub{color:#73dfff;font-size:.43em}.fnx-grid{display:grid;grid-template-columns:repeat(2,minmax(0,1fr));margin:0}.fnx-grid\u003ediv{padding:16px 18px 16px 0;border-top:1px solid var(--ln)}.fnx-grid\u003ediv:nth-child(even){padding-left:18px;border-left:1px solid rgba(125,190,255,.08)}.fnx-grid dt{margin:0 0 6px;color:#6ea9d8;font-size:9px;font-weight:800;letter-spacing:.13em;text-transform:uppercase}.fnx-grid dd{margin:0;color:#f1f8ff;font-size:13px;line-height:1.5;overflow-wrap:anywhere}.fnx-questions{display:grid;grid-template-columns:.62fr 1.38fr;gap:clamp(38px,6vw,84px);background:radial-gradient(40rem 24rem at 100% 10%,rgba(45,115,255,.16),transparent 70%),linear-gradient(150deg,rgba(4,38,95,.92),rgba(2,17,46,.98))}.fnx-questions h2{max-width:9ch}.fnx-q{padding:19px 0;border-top:1px solid var(--ln)}.fnx-q h3{margin:0 0 7px;color:#fff;font-size:17px}.fnx-q p{margin:0;font-size:13.5px}.fnx-sources{display:grid;grid-template-columns:.55fr 1.45fr;gap:clamp(35px,6vw,82px);background:linear-gradient(145deg,rgba(2,20,54,.99),rgba(4,43,105,.82))}.fnx-sources h2{max-width:9ch;margin:0;color:#fff;font-size:clamp(34px,4vw,52px);line-height:1;letter-spacing:-.045em}.fnx-links{display:grid}.fnx-links a{display:grid;grid-template-columns:76px 1fr auto;gap:16px;align-items:center;padding:14px 0;color:#fff;text-decoration:none;border-top:1px solid var(--ln)}.fnx-links span{color:#56cfff;font-size:10px;font-weight:800;letter-spacing:.11em}.fnx-links strong{font-size:13px;font-weight:650}.fnx-links i{color:#2be1ff;font-style:normal}html[data-nm-theme=\"light\"] .fnx-self,html[data-theme=\"light\"] .fnx-self{--txt:#082846;--cp:#446982;--ln:rgba(24,114,171,.17);color:#082846}html[data-nm-theme=\"light\"] .fnx-presentation,html[data-theme=\"light\"] .fnx-presentation,html[data-nm-theme=\"light\"] .fnx-quick,html[data-theme=\"light\"] .fnx-quick{background:linear-gradient(145deg,#f8fcff,#dcefff)}html[data-nm-theme=\"light\"] .fnx-self h2,html[data-theme=\"light\"] .fnx-self h2,html[data-nm-theme=\"light\"] .fnx-self h3,html[data-theme=\"light\"] .fnx-self h3,html[data-nm-theme=\"light\"] .fnx-fact dd,html[data-theme=\"light\"] .fnx-fact dd{color:#0a3456}.fnx-self .fnx-molecule{touch-action:pan-y}@media(max-width:900px){.fnx-presentation,.fnx-quick-head,.fnx-history,.fnx-science,.fnx-identity,.fnx-questions,.fnx-sources{grid-template-columns:1fr}.fnx-molecule{min-height:430px}}@media(max-width:620px){.fnx-self{margin:24px auto}.fnx-presentation{padding:34px 20px;border-radius:21px}.fnx-facts{grid-template-columns:1fr}.fnx-fact,.fnx-fact:nth-child(even){min-height:0;padding:15px 0;border-left:0}.fnx-quick{padding:36px 20px}.fnx-quick-grid{grid-template-columns:1fr}.fnx-key,.fnx-key+.fnx-key{min-height:0;padding:20px 0;border-left:0;border-top:1px solid var(--ln)}.fnx-deep{border-radius:21px}.fnx-deep\u003esummary{grid-template-columns:35px 1fr auto;gap:10px;padding:17px 15px}.fnx-deep-label strong{font-size:16px}.fnx-deep-label small{font-size:10px}.fnx-history,.fnx-science,.fnx-identity,.fnx-questions,.fnx-sources{padding:44px 20px}.fnx-molecule{min-height:340px}.fnx-molecule-stage{min-height:300px}.fnx-molecule-svg{width:115%}.fnx-grid{grid-template-columns:1fr}.fnx-grid\u003ediv:nth-child(even){padding-left:0;border-left:0}.fnx-links a{grid-template-columns:58px 1fr auto;gap:10px}}@media(prefers-reduced-motion:reduce){.fnx-self*,.fnx-self*::before,.fnx-self*::after{animation:none!important;transition:none!important}}\u003c\/style\u003e\n\u003cdiv class=\"fnx-self\" data-fnx-family=\"formula-combo-enfoque-mental\" data-fnx-hologram-master=\"\" data-fnx-visual-contract=\"r07-master-v06\"\u003e\n\u003csection class=\"fnx-presentation\"\u003e\u003cdiv class=\"fnx-presentation-copy\"\u003e\n\u003cp class=\"kicker\"\u003eESTA PRESENTACIÓN · COMBO DE 4 COMPUESTOS\u003c\/p\u003e\n\u003ch2\u003eLa presentación, en una mirada.\u003c\/h2\u003e\n\u003cp\u003eKit de cuatro referencias: Fasoracetam, Noopept, PRL-8-53 y Teacrina. La ficha documenta cada presentación y separa la evidencia de cada compuesto de cualquier supuesto efecto sinérgico del conjunto.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fnx-facts\"\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cdt\u003eFormato\u003c\/dt\u003e\n\u003cdd\u003eCombo · 4 productos\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cdt\u003eFamilias\u003c\/dt\u003e\n\u003cdd\u003eRacetam \/ derivado de racetam · compuesto experimental · metilurato\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cdt\u003eContenido\u003c\/dt\u003e\n\u003cdd\u003e3 líquidos + 1 polvo\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-fact\"\u003e\n\u003cdt\u003eDisponibilidad\u003c\/dt\u003e\n\u003cdd class=\"fnx-stock\"\u003eDisponible\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\u003c\/section\u003e\n\u003csection class=\"fnx-quick\"\u003e\u003cdiv class=\"fnx-quick-head\"\u003e\n\u003cdiv\u003e\n\u003cp class=\"kicker\"\u003eLO ESENCIAL EN SEGUNDOS\u003c\/p\u003e\n\u003ch2\u003eEl combo, en tres claves.\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cp\u003eCuatro compuestos con literatura independiente; no existe una sola molécula ni una evidencia clínica que valide el stack completo como unidad.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-quick-grid\"\u003e\n\u003carticle class=\"fnx-key fnx-card\"\u003e\u003cspan class=\"fnx-number fnx-n\"\u003e01\u003c\/span\u003e\u003ch3\u003eCuatro referencias\u003c\/h3\u003e\n\u003cp\u003eFasoracetam 750 mg \/ 30 mL · Noopept 600 mg \/ 30 mL · PRL-8-53 600 mg \/ 30 mL · Teacrina 5 g.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-key fnx-card\"\u003e\u003cspan class=\"fnx-number fnx-n\"\u003e02\u003c\/span\u003e\u003ch3\u003eEvidencia separada\u003c\/h3\u003e\n\u003cp\u003eFasoracetam, Noopept, PRL-8-53 y teacrina tienen líneas de investigación distintas, con modelos, poblaciones y desenlaces no equivalentes.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-key fnx-card\"\u003e\u003cspan class=\"fnx-number fnx-n\"\u003e03\u003c\/span\u003e\u003ch3\u003eSinergia no demostrada\u003c\/h3\u003e\n\u003cp\u003eQue varios compuestos tengan mecanismos investigados no demuestra que combinarlos produzca un beneficio aditivo o superior.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003cdetails class=\"fnx-deep\"\u003e\u003csummary\u003e\u003cspan aria-hidden=\"true\" class=\"fnx-signal\"\u003e\u003c\/span\u003e\u003cspan class=\"fnx-deep-label\"\u003e\u003cstrong\u003ePROFUNDIZA\u003c\/strong\u003e\u003csmall\u003eComponentes · evidencia · mecanismos · límites\u003c\/small\u003e\u003c\/span\u003e\u003cspan aria-hidden=\"true\" class=\"fnx-arrow\"\u003e↓\u003c\/span\u003e\u003c\/summary\u003e\u003cdiv class=\"fnx-deep-content\"\u003e\n\u003csection class=\"fnx-history\"\u003e\u003cheader\u003e\u003cp class=\"kicker\"\u003eHISTORIA Y CONTEXTO\u003c\/p\u003e\n\u003ch2\u003eCuatro líneas de investigación, no una sola historia.\u003c\/h2\u003e\n\u003c\/header\u003e\u003col class=\"fnx-tl\" data-fnx-history-track=\"\"\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003e1978\u003c\/p\u003e\n\u003ch3\u003ePRL-8-53 en humanos\u003c\/h3\u003e\n\u003cp\u003eUn estudio pequeño evaluó aprendizaje y retención verbal bajo condiciones controladas; sigue siendo una base clínica limitada.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003eNOOPEPT\u003c\/p\u003e\n\u003ch3\u003eModelos preclínicos y factores neurotróficos\u003c\/h3\u003e\n\u003cp\u003eLa literatura incluye efectos sobre BDNF\/pro-BDNF y otros mecanismos en modelos experimentales; eso no establece un resultado del combo.\u003c\/p\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cspan class=\"fnx-node\"\u003e\u003c\/span\u003e\u003cp class=\"fnx-date\"\u003eTEACRINA\u003c\/p\u003e\n\u003ch3\u003eEnergía y cognición bajo estudio\u003c\/h3\u003e\n\u003cp\u003eEnsayos controlados han evaluado energía, estado de ánimo y rendimiento cognitivo, con resultados que dependen de formulación y contexto.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\u003c\/section\u003e\n\u003csection class=\"fnx-science\"\u003e\u003cdiv class=\"fnx-molecule\" data-fnx-molecule-hologram=\"\"\u003e\n\u003cdiv class=\"fnx-molecule-stage\"\u003e\n\u003csvg aria-label=\"Matriz holográfica de cuatro componentes del Combo de 4 Compuestos\" class=\"fnx-molecule-svg\" role=\"img\" viewbox=\"0 0 760 450\"\u003e\u003cg fill=\"none\" stroke-linecap=\"round\"\u003e\u003ccircle cx=\"380\" cy=\"220\" r=\"84\" stroke=\"#bff8ff\" stroke-width=\"2.5\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"380\" cy=\"220\" opacity=\".45\" r=\"136\" stroke=\"#2be1ff\" stroke-width=\"1.5\"\u003e\u003c\/circle\u003e\u003cline stroke=\"#8ce0ff\" stroke-width=\"3\" x1=\"320\" x2=\"180\" y1=\"165\" y2=\"100\"\u003e\u003c\/line\u003e\u003cline stroke=\"#8ce0ff\" stroke-width=\"3\" x1=\"440\" x2=\"580\" y1=\"165\" y2=\"100\"\u003e\u003c\/line\u003e\u003cline stroke=\"#8ce0ff\" stroke-width=\"3\" x1=\"320\" x2=\"180\" y1=\"275\" y2=\"350\"\u003e\u003c\/line\u003e\u003cline stroke=\"#8ce0ff\" stroke-width=\"3\" x1=\"440\" x2=\"580\" y1=\"275\" y2=\"350\"\u003e\u003c\/line\u003e\u003c\/g\u003e\u003cg fill=\"#06265e\" stroke=\"#bff8ff\" stroke-width=\"2\"\u003e\u003ccircle cx=\"380\" cy=\"220\" r=\"60\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"180\" cy=\"100\" r=\"54\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"580\" cy=\"100\" r=\"54\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"180\" cy=\"350\" r=\"54\"\u003e\u003c\/circle\u003e\u003ccircle cx=\"580\" cy=\"350\" r=\"54\"\u003e\u003c\/circle\u003e\u003c\/g\u003e\u003cg fill=\"#fff\" font-size=\"12\" font-weight=\"800\" text-anchor=\"middle\"\u003e\u003ctext x=\"380\" y=\"216\"\u003eCOMBO\u003c\/text\u003e\u003ctext fill=\"#8fd7f2\" font-size=\"9\" x=\"380\" y=\"234\"\u003e4 COMPONENTES\u003c\/text\u003e\u003ctext x=\"180\" y=\"96\"\u003eFASORACETAM\u003c\/text\u003e\u003ctext fill=\"#8fd7f2\" font-size=\"9\" x=\"180\" y=\"114\"\u003e750 mg \/ 30 mL\u003c\/text\u003e\u003ctext x=\"580\" y=\"96\"\u003eNOOPEPT\u003c\/text\u003e\u003ctext fill=\"#8fd7f2\" font-size=\"9\" x=\"580\" y=\"114\"\u003e600 mg \/ 30 mL\u003c\/text\u003e\u003ctext x=\"180\" y=\"346\"\u003ePRL-8-53\u003c\/text\u003e\u003ctext fill=\"#8fd7f2\" font-size=\"9\" x=\"180\" y=\"364\"\u003e600 mg \/ 30 mL\u003c\/text\u003e\u003ctext x=\"580\" y=\"346\"\u003eTEACRINA\u003c\/text\u003e\u003ctext fill=\"#8fd7f2\" font-size=\"9\" x=\"580\" y=\"364\"\u003e5 g · polvo\u003c\/text\u003e\u003c\/g\u003e\u003c\/svg\u003e\u003cdiv class=\"fnx-platform\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-molecule-meta\"\u003e\n\u003cstrong\u003eCOMBO DE 4 COMPUESTOS\u003c\/strong\u003e\u003cspan\u003e4 referencias · evidencia independiente\u003cbr\u003e3 líquidos + 1 polvo\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"fnx-science-copy\"\u003e\n\u003cp class=\"kicker\"\u003eLA CIENCIA DETRÁS\u003c\/p\u003e\n\u003ch2\u003eUna matriz de compuestos distintos.\u003c\/h2\u003e\n\u003cp class=\"fnx-science-lead\"\u003eEl stage holográfico representa el conjunto sin inventar una molécula única; la plataforma permanece fija y el runtime central gobierna la interacción.\u003c\/p\u003e\n\u003cdiv\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e01\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eFasoracetam\u003c\/h3\u003e\n\u003cp\u003eSe ha investigado en señalización metabotrópica de glutamato y en una población clínica genética específica; no se presenta aquí como agonista GABA-B directo.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e02\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eNoopept\u003c\/h3\u003e\n\u003cp\u003eLa literatura preclínica incluye vías neurotróficas e inflamatorias; esos mecanismos no validan una mejora general de memoria en este combo.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e03\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003ePRL-8-53\u003c\/h3\u003e\n\u003cp\u003eExiste un estudio humano histórico sobre aprendizaje y retención verbal, pero la base clínica es reducida y no demuestra eficacia del stack completo.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-topic\"\u003e\u003cspan\u003e04\u003c\/span\u003e\u003cdiv\u003e\n\u003ch3\u003eTeacrina\u003c\/h3\u003e\n\u003cp\u003eEnsayos humanos han explorado energía, fatiga y cognición; la evidencia no sostiene por sí sola “sin tolerancia” como resultado universal.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/article\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"fnx-identity\"\u003e\u003cheader\u003e\u003cp class=\"kicker\"\u003eIDENTIDAD DEL COMBO\u003c\/p\u003e\n\u003ch2\u003eCuatro productos, cuatro identidades.\u003c\/h2\u003e\n\u003c\/header\u003e\u003cdiv class=\"fnx-formula\"\u003e4\u003cbr\u003e\u003cspan style=\"font-size:.42em;color:#73dfff;\"\u003ePRODUCTOS\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdl class=\"fnx-grid\"\u003e\n\u003cdiv\u003e\n\u003cdt\u003eFasoracetam\u003c\/dt\u003e\n\u003cdd\u003eScience · solución 750 mg · 30 mL\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eNoopept\u003c\/dt\u003e\n\u003cdd\u003eScience · solución sublingual 600 mg · 30 mL\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003ePRL-8-53\u003c\/dt\u003e\n\u003cdd\u003eScience · solución 600 mg · 30 mL\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eTeacrina\u003c\/dt\u003e\n\u003cdd\u003eBotany · polvo · 5 g\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eFormato del SKU\u003c\/dt\u003e\n\u003cdd\u003eCombo de cuatro referencias\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cdt\u003eSinergia clínica\u003c\/dt\u003e\n\u003cdd\u003eNo establecida como unidad\u003c\/dd\u003e\n\u003c\/div\u003e\n\u003c\/dl\u003e\u003c\/section\u003e\n\u003csection class=\"fnx-questions\"\u003e\u003cheader\u003e\u003cp class=\"kicker\"\u003ePREGUNTAS CLAVE\u003c\/p\u003e\n\u003ch2\u003eEl combo, con contexto.\u003c\/h2\u003e\u003c\/header\u003e\u003cdiv\u003e\n\u003carticle class=\"fnx-q\"\u003e\u003ch3\u003e¿Los cuatro compuestos han sido estudiados juntos?\u003c\/h3\u003e\n\u003cp\u003eNo hay en esta ficha evidencia de un ensayo clínico que valide esta combinación exacta como unidad.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-q\"\u003e\u003ch3\u003e¿Fasoracetam es un agonista GABA-B?\u003c\/h3\u003e\n\u003cp\u003eNo se presenta así. La literatura clínica recuperada lo describe como activador de señalización mGluR en un contexto específico.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-q\"\u003e\u003ch3\u003e¿PRL-8-53 tiene evidencia humana?\u003c\/h3\u003e\n\u003cp\u003eSí, existe un estudio histórico pequeño sobre aprendizaje y retención verbal; su alcance es limitado.\u003c\/p\u003e\u003c\/article\u003e\n\u003carticle class=\"fnx-q\"\u003e\u003ch3\u003e¿Teacrina significa energía sin tolerancia garantizada?\u003c\/h3\u003e\n\u003cp\u003eNo. Hay investigación humana sobre energía y cognición, pero no justifica una garantía universal de ausencia de tolerancia.\u003c\/p\u003e\u003c\/article\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003csection class=\"fnx-sources\"\u003e\u003cheader\u003e\u003cp class=\"kicker\"\u003eFUENTES CONSULTADAS\u003c\/p\u003e\n\u003ch2\u003eRastrea cada componente.\u003c\/h2\u003e\u003c\/header\u003e\u003cdiv class=\"fnx-links\"\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29339723\/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cspan\u003e2018\u003c\/span\u003e\u003cstrong\u003eFasoracetam · mGluR · estudio clínico\u003c\/strong\u003e\u003ci\u003e↗\u003c\/i\u003e\u003c\/a\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/418433\/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cspan\u003e1978\u003c\/span\u003e\u003cstrong\u003ePRL-8-53 · aprendizaje y retención en humanos\u003c\/strong\u003e\u003ci\u003e↗\u003c\/i\u003e\u003c\/a\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33644478\/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cspan\u003e2021\u003c\/span\u003e\u003cstrong\u003eNoopept · BDNF \/ pro-BDNF · modelo experimental\u003c\/strong\u003e\u003ci\u003e↗\u003c\/i\u003e\u003c\/a\u003e\n\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26610558\/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003e\u003cspan\u003e2015\u003c\/span\u003e\u003cstrong\u003eTeacrina · cognición y estado de ánimo · ensayo controlado\u003c\/strong\u003e\u003ci\u003e↗\u003c\/i\u003e\u003c\/a\u003e\n\u003c\/div\u003e\u003c\/section\u003e\n\u003c\/div\u003e\u003c\/details\u003e\n\u003c\/div\u003e","brand":"Nootrópicos México","offers":[{"title":"Default Title","offer_id":43188678361155,"sku":null,"price":4479.0,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1156\/1718\/files\/combo.png?v=1777333680","url":"https:\/\/nootropicosmexico.com\/products\/combo-noopept-fasoracetam-prl-8-53-teacrina","provider":"Nootrópicos México","version":"1.0","type":"link"}